4.8 Article

Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Protiens

期刊

FRONTIERS IN IMMUNOLOGY
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2017.00976

关键词

autoimmune regulator; autoantibodies; immune tolerance; thymus; autoantigen

资金

  1. Wellcome Trust [106292/Z/14/Z]
  2. Cancer Research UK
  3. European Union [2014-2020.4.01.15-0012]
  4. CoE of Estonian ICT research EXCITE
  5. Estonian Research Council [IUT2-2, IUT34-4]
  6. Novo Nordisk Fonden [NNF14OC0011005] Funding Source: researchfish
  7. Wellcome Trust [106292/Z/14/Z] Funding Source: researchfish

向作者/读者索取更多资源

High titer autoantibodies produced by B lymphocytes are clinically important features of many common autoimmune diseases. APECED patients with deficient autoimmune regulator (AIRE) gene collectively display a broad repertoire of high titer autoantibodies, including some which are pathognomonic for major autoimmune diseases. AIRE deficiency severely reduces thymic expression of gene-products ordinarily restricted to discrete peripheral tissues, and developing T cells reactive to those gene-products are not inactivated during their development. However, the extent of the autoantibody repertoire in APECED and its relation to thymic expression of self-antigens are unclear. We here undertook a broad protein array approach to assess autoantibody repertoire in APECED patients. Our results show that in addition to shared autoantigen reactivities, APECED patients display high inter-individual variation in their autoantigen profiles, which collectively are enriched in evolutionarily conserved, cytosolic and nuclear phosphoproteins. The APECED autoantigens have two major origins; proteins expressed in thymic medullary epithelial cells and proteins expressed in lymphoid cells. These findings support the hypothesis that specific protein properties strongly contribute to the etiology of B cell autoimmunity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据